261 related articles for article (PubMed ID: 23935499)
1. Rational design of a live attenuated dengue vaccine: 2'-o-methyltransferase mutants are highly attenuated and immunogenic in mice and macaques.
Züst R; Dong H; Li XF; Chang DC; Zhang B; Balakrishnan T; Toh YX; Jiang T; Li SH; Deng YQ; Ellis BR; Ellis EM; Poidinger M; Zolezzi F; Qin CF; Shi PY; Fink K
PLoS Pathog; 2013; 9(8):e1003521. PubMed ID: 23935499
[TBL] [Abstract][Full Text] [Related]
2. Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Delta30 with those of DEN1.
Blaney JE; Sathe NS; Hanson CT; Firestone CY; Murphy BR; Whitehead SS
Virol J; 2007 Feb; 4():23. PubMed ID: 17328799
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a candidate tetravalent vaccine based on 2'-O-methyltransferase mutants.
Züst R; Li SH; Xie X; Velumani S; Chng M; Toh YX; Zou J; Dong H; Shan C; Pang J; Qin CF; Newell EW; Shi PY; Fink K
PLoS One; 2018; 13(1):e0189262. PubMed ID: 29298302
[TBL] [Abstract][Full Text] [Related]
4. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
[TBL] [Abstract][Full Text] [Related]
5. A chimeric dengue virus vaccine using Japanese encephalitis virus vaccine strain SA14-14-2 as backbone is immunogenic and protective against either parental virus in mice and nonhuman primates.
Li XF; Deng YQ; Yang HQ; Zhao H; Jiang T; Yu XD; Li SH; Ye Q; Zhu SY; Wang HJ; Zhang Y; Ma J; Yu YX; Liu ZY; Li YH; Qin ED; Shi PY; Qin CF
J Virol; 2013 Dec; 87(24):13694-705. PubMed ID: 24109223
[TBL] [Abstract][Full Text] [Related]
6. A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus.
Raviprakash K; Wang D; Ewing D; Holman DH; Block K; Woraratanadharm J; Chen L; Hayes C; Dong JY; Porter K
J Virol; 2008 Jul; 82(14):6927-34. PubMed ID: 18480438
[TBL] [Abstract][Full Text] [Related]
7. Extensive genomic recoding by codon-pair deoptimization selective for mammals is a flexible tool to generate attenuated vaccine candidates for dengue virus 2.
Stauft CB; Song Y; Gorbatsevych O; Pantoja P; Rodriguez IV; Futcher B; Sariol CA; Wimmer E
Virology; 2019 Nov; 537():237-245. PubMed ID: 31539771
[TBL] [Abstract][Full Text] [Related]
8. Genetic and phenotypic characterization of manufacturing seeds for a tetravalent dengue vaccine (DENVax).
Huang CY; Kinney RM; Livengood JA; Bolling B; Arguello JJ; Luy BE; Silengo SJ; Boroughs KL; Stovall JL; Kalanidhi AP; Brault AC; Osorio JE; Stinchcomb DT
PLoS Negl Trop Dis; 2013; 7(5):e2243. PubMed ID: 23738026
[TBL] [Abstract][Full Text] [Related]
9. Generation and preclinical evaluation of a DENV-1/2 prM+E chimeric live attenuated vaccine candidate with enhanced prM cleavage.
Keelapang P; Nitatpattana N; Suphatrakul A; Punyahathaikul S; Sriburi R; Pulmanausahakul R; Pichyangkul S; Malasit P; Yoksan S; Sittisombut N
Vaccine; 2013 Oct; 31(44):5134-40. PubMed ID: 23973247
[TBL] [Abstract][Full Text] [Related]
10. Using recombinant DNA technology for the development of live-attenuated dengue vaccines.
Lee HC; Butler M; Wu SC
Enzyme Microb Technol; 2012 Jul; 51(2):67-72. PubMed ID: 22664189
[TBL] [Abstract][Full Text] [Related]
11. Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3' untranslated region (3'-UTR) or by exchange of the DENV-3 3'-UTR with that of DENV-4.
Blaney JE; Sathe NS; Goddard L; Hanson CT; Romero TA; Hanley KA; Murphy BR; Whitehead SS
Vaccine; 2008 Feb; 26(6):817-28. PubMed ID: 18191005
[TBL] [Abstract][Full Text] [Related]
12. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP
J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852
[TBL] [Abstract][Full Text] [Related]
13. Use of a Recombinant Gamma-2 Herpesvirus Vaccine Vector against Dengue Virus in Rhesus Monkeys.
Bischof GF; Magnani DM; Ricciardi M; Shin YC; Domingues A; Bailey VK; Gonzalez-Nieto L; Rakasz EG; Watkins DI; Desrosiers RC
J Virol; 2017 Aug; 91(16):. PubMed ID: 28592531
[TBL] [Abstract][Full Text] [Related]
14. Prospects for a dengue virus vaccine.
Whitehead SS; Blaney JE; Durbin AP; Murphy BR
Nat Rev Microbiol; 2007 Jul; 5(7):518-28. PubMed ID: 17558424
[TBL] [Abstract][Full Text] [Related]
15. Universal Dengue Vaccine Elicits Neutralizing Antibodies against Strains from All Four Dengue Virus Serotypes.
Uno N; Ross TM
J Virol; 2021 Jan; 95(4):. PubMed ID: 33208445
[TBL] [Abstract][Full Text] [Related]
16. Current progress in dengue vaccines.
Wan SW; Lin CF; Wang S; Chen YH; Yeh TM; Liu HS; Anderson R; Lin YS
J Biomed Sci; 2013 Jun; 20(1):37. PubMed ID: 23758699
[TBL] [Abstract][Full Text] [Related]
17. Live Cell Analysis and Mathematical Modeling Identify Determinants of Attenuation of Dengue Virus 2'-O-Methylation Mutant.
Schmid B; Rinas M; Ruggieri A; Acosta EG; Bartenschlager M; Reuter A; Fischl W; Harder N; Bergeest JP; Flossdorf M; Rohr K; Höfer T; Bartenschlager R
PLoS Pathog; 2015 Dec; 11(12):e1005345. PubMed ID: 26720415
[TBL] [Abstract][Full Text] [Related]
18. Historical discourse on the development of the live attenuated tetravalent dengue vaccine candidate TV003/TV005.
Durbin AP
Curr Opin Virol; 2020 Aug; 43():79-87. PubMed ID: 33164790
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and efficacy of flagellin-envelope fusion dengue vaccines in mice and monkeys.
Liu G; Song L; Beasley DW; Putnak R; Parent J; Misczak J; Li H; Reiserova L; Liu X; Tian H; Liu W; Labonte D; Duan L; Kim Y; Travalent L; Wigington D; Weaver B; Tussey L
Clin Vaccine Immunol; 2015 May; 22(5):516-25. PubMed ID: 25761459
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of molecular strategies to develop a live dengue vaccine.
Lai CJ; Bray M; Men R; Cahour A; Chen W; Kawano H; Tadano M; Hiramatsu K; Tokimatsu I; Pletnev A; Arakai S; Shameem G; Rinaudo M
Clin Diagn Virol; 1998 Jul; 10(2-3):173-9. PubMed ID: 9741643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
